6,000-Year-Old Knee Joints Suggest Osteoarthritis Isn’t Just Wear And Tear
Osteoarthritis is considered a wear and tear disease, but based on a study of human skeletons it is much more prevalent now.
Osteoarthritis is considered a wear and tear disease, but based on a study of human skeletons it is much more prevalent now.
Ever wonder how professional athletes bounce back from joint injuries so quickly?
Dr. Eric Topol, author of the XXX book “The Patient Will See You Now”, describes his journey to diagnose and treat his own bad knees.
Jane Brody, a personal health columnist for the New York Times, describes her journey to find relief from chronic knee pain while avoiding (unsuccessfully) a knee replacement.
Arthroventions took a break from saving joints to watch the #SolarEclipse on our roof-top deck at #Battery621. Want to see NASA’s coverage of the #SolarEclipse2017 ? You can view additional articles from Arthroventions on our News & Blog
Kolon Life Sciences has attained approval in South Korea for a first-in-class cell-mediated gene therapy designed to treat osteoarthritis through regeneration of cartilage. “Kolon has said injection of Invossa has been shown in Phase III trials in Korea to ease the symptoms of about 84% of patients – while 88% of U.S. patients treated with Read more about Can Gene Therapy Stop the Progression of Osteoarthritis?[…]
Animals experience the same age-related ailments that aging humans face, including arthritis. See Brookfield Zoo’s approach using Platelet-Rich Plasma: Brookfield Zoo’s Oldest Animal Gets Knee Scope to Treat Arthritis
Stem Cell Joint Injections: Anecdotally Patients Improve… but Western Medicine Still Struggling to Prove It Stem Cell Injections: Emerging Option for Joint Pain Relief https://health.clevelandclinic.org/2017/07/stem-cell-injections-emerging-option-for-joint-pain-relief/
Yesterday was a big day for Arthroventions as we celebrated our first sale by cutting my hair. I am so proud of our team and their hard work over the last year and a half. Launching a medical device company has been one of the hardest and most challenging endeavors we have all undertaken. Read more about Arthro CEO Takes a Haircut Or Why Your CEO Should Not Bet Your Sales Team[…]
On Thursday, Arthroventions reflected on customer discovery and validated learning as part of the National Science Foundation’s (NSF) Innovation Corps (I-Corps™) program, hosted by the Colorado Clinical and Translational Science Institute (CCTSI). The I-Corps program provides real-world, hands-on, immersive learning about what it takes to successfully commercialize products and services that customers want. During the Read more about Arthroventions Reflects on the NSF’s I-Corps Program and Customer Discovery[…]